Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionDnB Asset Management AS
Latest Disclosed Ownership288,731 shares
Latest Disclosed Value $ 23,121,578
DnB Asset Management AS reports 3.83% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 14, 2026 - DnB Asset Management AS filed a 13F-HR form disclosing ownership of 288,731 shares of Edwards Lifesciences Corporation (MX:EW) valued at $23,121,578 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 300,237 shares of Edwards Lifesciences Corporation. This represents a change in shares of -3.83% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F Edwards Lifesciences COM 28176E108 288,731 -11,506 -3.83 23,122 -9.67 0.0824
2026-02-05 2025-12-31 13F Edwards Lifesciences COM 28176E108 300,237 -4,418 -1.45 25,595 8.03 0.0893
2025-11-12 2025-09-30 13F Edwards Lifesciences COM 28176E108 304,655 6,861 2.30 23,693 1.73 0.0886
2025-08-12 2025-06-30 13F Edwards Lifesciences COM 28176E108 297,794 -18,320 -5.80 23,290 1.65 0.0966
2025-05-15 2025-03-31 13F Edwards Lifesciences COM 28176E108 316,114 -11,810 -3.60 22,912 -5.62 0.1056
2025-02-12 2024-12-31 13F Edwards Lifesciences COM 28176E108 327,924 11,348 3.58 24,276 16.21 0.1050
2024-11-12 2024-09-30 13F Edwards Lifesciences COM 28176E108 316,576 81,265 34.54 20,891 -3.89 0.0943
2024-07-05 2024-06-30 13F Edwards Lifesciences common 28176E108 235,311 39,015 19.88 21,736 15.87 0.1037
2024-04-12 2024-03-31 13F Edwards Lifesciences common 28176E108 196,296 -46,795 -19.25 18,758 1.20 0.0978
2024-01-04 2023-12-31 13F Edwards Lifesciences common 28176E108 243,091 435 0.18 18,536 10.26 0.0962
2023-10-13 2023-09-30 13F Edwards Lifesciences common 28176E108 242,656 20,926 9.44 16,811 -19.62 0.1004
2023-07-10 2023-06-30 13F/A-1 Edwards Lifesciences common 28176E108 221,730 19,379 9.58 20,916 24.94 0.1202
2023-07-06 2023-06-30 13F Edwards Lifesciences common 28176E108 221,730 19,379 20,916 0.1231
2023-04-20 2023-03-31 13F Edwards Lifesciences common 28176E108 202,351 -2,837 -1.38 16,740 9.35 0.1061
2023-01-12 2022-12-31 13F Edwards Lifesciences common 28176E108 205,188 28,067 15.85 15,309 4.61 0.1079
2022-10-11 2022-09-30 13F Edwards Lifesciences common 28176E108 177,121 19,149 12.12 14,636 -2.57 0.1129
2022-07-08 2022-06-30 13F Edwards Lifesciences common 28176E108 157,972 20,452 14.87 15,022 -7.21 0.1056
2022-04-08 2022-03-31 13F Edwards Lifesciences common 28176E108 137,520 -17,818 -11.47 16,189 -19.56 0.0963
2022-01-12 2021-12-31 13F Edwards Lifesciences common 28176E108 155,338 6,070 4.07 20,124 19.09 0.1181
2021-10-15 2021-09-30 13F Edwards Lifesciences common 28176E108 149,268 46,098 44.68 16,899 58.15 0.1097
2021-07-06 2021-06-30 13F Edwards Lifesciences common 28176E108 103,170 -42,150 -29.00 10,685 -12.09 0.0708
2021-04-15 2021-03-31 13F Edwards Lifesciences common 28176E108 145,320 32,766 29.11 12,155 18.37 0.0887
2021-01-19 2020-12-31 13F Edwards Lifesciences common 28176E108 112,554 14,497 14.78 10,268 31.20 0.0900
2020-10-14 2020-09-30 13F Edwards Lifesciences common 28176E108 98,057 24,165 32.70 7,827 53.27 0.0832
2020-07-08 2020-06-30 13F Edwards Lifesciences common 28176E108 73,892 51,543 230.63 5,107 21.14 0.0600
2020-04-17 2020-03-31 13F Edwards Lifesciences common 28176E108 22,349 -2,858 -11.34 4,215 -28.32 0.0620
2020-01-13 2019-12-31 13F Edwards Lifesciences common 28176E108 25,207 2,730 12.15 5,881 18.98 0.0578
2019-10-16 2019-09-30 13F Edwards Lifesciences common 28176E108 22,477 1,707 8.22 4,943 28.80 0.0558
2019-07-08 2019-06-30 13F Edwards Lifesciences common 28176E108 20,770 -1,827 -8.09 3,837 -11.24 0.0442
2019-04-11 2019-03-31 13F Edwards Lifesciences common 28176E108 22,597 -2,155 -8.71 4,323 14.03 0.0493
2019-01-15 2018-12-31 13F Edwards Lifesciences common 28176E108 24,752 -1,305 -5.01 3,791 -16.42 0.0492
2018-10-10 2018-09-30 13F Edwards Lifesciences common 28176E108 26,057 -689 -2.58 4,537 16.52 0.0510
2018-07-06 2018-06-30 13F Edwards Lifesciences common 28176E108 26,746 1,500 5.94 3,893 10.53 0.0459
2018-04-11 2018-03-31 13F Edwards Lifesciences common 28176E108 25,246 1,700 7.22 3,522 32.76 0.0424
2018-01-10 2017-12-31 13F Edwards Lifesciences common 28176E108 23,546 1,300 5.84 2,654 9.13 0.0320
2017-10-11 2017-09-30 13F Edwards Lifesciences common 28176E108 22,246 -600 -2.63 2,432 -10.00 0.0323
2017-07-06 2017-06-30 13F Edwards Lifesciences common 28176E108 22,846 -1,600 -6.55 2,701 17.49 0.0394
2017-04-19 2017-03-31 13F Edwards Lifesciences common 28176E108 24,446 4,300 21.34 2,300 21.83 0.0361
2017-01-17 2016-12-31 13F Edwards Lifesciences common 28176E108 20,146 1,700 9.22 1,888 -15.11 0.0346
2016-10-28 2016-09-30 13F Edwards Lifesciences common 28176E108 18,446 400 2.22 2,224 23.57 0.0437
2016-07-08 2016-06-30 13F Edwards Lifesciences common 28176E108 18,046 -4,700 -20.66 1,800 -10.32 0.0381
2016-04-11 2016-03-31 13F Edwards Lifesciences common 28176E108 22,746 4,600 25.35 2,006 39.99 0.0419
2016-01-20 2015-12-31 13F Edwards Lifesciences common 28176E108 18,146 18,146 1,433 0.0307
2015-10-21 2015-09-30 13F Edwards Lifesciences common 28176E108 0 -10,123 -100.00 0 -100.00
2015-07-07 2015-06-30 13F Edwards Lifesciences common 28176E108 10,123 -18,300 -64.38 1,442 -22.90 0.0318
2014-01-27 2013-12-31 13F Edwards Lifesciences common 28176E108 28,423 1,000 3.65 1,869 -2.10 0.0439
2013-10-17 2013-09-30 13F Edwards Lifesciences common 28176E108 27,423 9,600 53.86 1,909 59.48 0.0523
2013-07-31 2013-06-30 13F Edwards Lifesciences common 28176E108 17,823 17,823 1,198 0.0355
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.